Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated falciparum malaria in Comoros
ACTRN12617001051336Phase 4Completed
- Sponsor
- Ministry of Health of Comoros
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in malaria and Falciparum malaria (PF), sponsored by Ministry of Health of Comoros. Primary endpoints: Treatment failure rate, Adequate clinical and parasitological response and 1 more. Started Jul 2017; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12617001051336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001051336.